|
K. oxytocagroupvs. K. pneumoniaegroup
|
2.39
|
[1.05,5.53]
|
2.01
|
0.044
|
|
K. oxytocavs.K. michiganensis
|
0.75
|
[0.42,1.34]
|
− 0.97
|
0.33
|
|
K. oxytoca vs. K. grimontii
|
0.64
|
[0.30,1.36]
|
− 1.15
|
0.252
|
|
K. pneumoniae vs. K. variicola
|
1.08
|
[0.69,1.65]
|
0.35
|
0.724
|
|
K. pneumoniae vs. K. quasipneumoniae
|
0.64
|
[0.35,1.15]
|
− 1.44
|
0.149
|
|
CCI
|
1.14
|
[1.04,1.25]
|
2.95
|
0.003
|
|
Age (centred, 10 years increase)
|
0.84
|
[0.75,0.95]
|
− 2.78
|
0.005
|
|
Female (ratio)
|
0.54
|
[0.37,0.79]
|
− 3.17
|
0.002
|
|
Immunosuppression
|
0.5
|
[0.29,0.86]
|
− 2.5
|
0.012
|
|
Resistance to 3rd-generation cephalosporins
|
1.31
|
[0.44,3.74]
|
0.5
|
0.618
|
|
Antibiotic treatment at entry or during hospitalization
|
3.11
|
[1.44,6.49]
|
2.92
|
0.003
|
